Clinical efficacy and safety of Shensong Yangxin capsule-antiarrhythmic drug combination for paroxysmal atrial fibrillation: A meta-analysis of randomized controlled trialsXinfu Cao, Xiaolong Li, Chao Tang et al.|European Journal of Integrative Medicine|2023Cited by 2
Development of a Nomogram That Predicts the Risk of Atrial Fibrillation in Patients with Coronary Heart DiseaseXinfu Cao, Zhenhua Gu, Yi Sun et al.|Risk Management and Healthcare Policy|2024Cited by 2